High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma
Open Access
- 9 July 1999
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (11) , 1781-1785
- https://doi.org/10.1038/sj.bjc.6690597
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesotheliomaCancer, 1995
- Interferon (IFN)-α and IFN-γ in combination with methotrexateAnti-Cancer Drugs, 1995
- High dose doxorubicin plus cisplatin in the treatment of unresectable mesotheliomas: report of four casesLung Cancer, 1994
- Recombinant Interferon Alpha-2b in the Treatment of Diffuse Malignant Pleural MesotheliomaAmerican Journal of Clinical Oncology, 1994
- Treatment of Malignant Pleural Mesothelioma with Cisplatin, Mitomycin C and Alpha InterferonOncology, 1994
- in vitro effects of recombinant human interferon gamma on human mesothelioma cell linesInternational Journal of Cancer, 1993
- Effect of Interferon-α2aMalignant MesotheliomaJournal of Interferon Research, 1993
- Effects of natural interferon α, natural tumor necrosis factor α and their combination on human mesothelioma xenografts in nude miceCancer Immunology, Immunotherapy, 1993
- Phase II Evaluation of Recombinant Interferon-β (LFN-βser) in Patients with Diffuse Mesothelioma: A Southwest Oncology Group StudyJournal of Interferon Research, 1990
- High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesotheliomaCancer, 1982